<DOC>
	<DOC>NCT00448630</DOC>
	<brief_summary>The purpose of the study is to find and follow-up the metabolic syndrome parameters on patients administering atypical antipsychotics.</brief_summary>
	<brief_title>An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics</brief_title>
	<detailed_description>Sampling Method Details: Group of patients using the same atypical anti-psychotic.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Female and male patients diagnosed as schizophrenia by the Diagnostic and Statistical Manual of Mental Disorders. Age between 1845 years Patients who started atypical antipsychotic drug treatment or patients who switched from the previous conventional or atypical antipsychotic treatment to another atypical antipsychotic drug treatment by the decision of their physicians. Patients who are pregnant or considering pregnancy. Patients who were included in a similar study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Atypical antipsychotics, Metabolic syndrome, Safety</keyword>
</DOC>